Last $3.96 USD
Change Today -0.10 / -2.46%
Volume 1.5M
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul K. Wotton Ph.D.

Chief Executive Officer, President and Director, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 4 different industries.

See Board Relationships
51$1,408,066
As of Fiscal Year 2012

Background*

Dr. Paul K. Wotton PhD has been the Chief Executive Officer of Antares Pharma Inc. since October 2008 and as its President since July 2008. Dr. Wotton served as the Chief Executive Officer and President of Topigen Pharmaceuticals Inc. until March 2008. He served as Chief Operating Officer of Antares Pharma Inc. from July 2008 to October 2008. Prior to Topigen, he served as Global Head of Business Development at SkyePharma PLC, where he managed the business development ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

Former Chief Executive Officer, President and Executive Director
2004-Present
Chief Executive Officer, President and Director
2008-Present
Director

Education*

Bachelor's Degree
University Of London
PhD
Nottingham University
MBA
Kingston Business School

Other Affiliations*

Annual Compensation*

Salary$477,000
Total Annual Compensation$477,000

Stock Options*

Restricted Stock Awards$25,900
All Other Compensation$8,500
Exercised Options25,000
Exercised Options Value$87,508
Exercisable Options1,305,691
Exercisable Options Value$3,750,323
Unexercisable Options335,102
Unexercisable Options Value$350,102
Total Value of Options$4,187,933
Total Number of Options1,665,793

Total Compensation*

Total Annual Cash Compensation$915,500
Total Short Term Compensation$477,000
Other Long Term Compensation$34,400
Total Calculated Compensation$1,408,066
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $3.96 USD -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$465.0K
Harry F. Hixson Jr., Ph.D.Chairman and Chief Executive Officer
Sequenom Inc.
$500.0K
Christopher J. Calhoun Co-Founder, Vice Chairman, Chief Executive Officer, Secretary and Member of Executive Committee
Cytori Therapeutics, Inc.
$467.9K
Barry G. Caldwell Chief Executive Officer, President and Director
STAAR Surgical Company
$458.4K
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$475.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.